Evidence map›Paper›PMID 24997597›Full record

ArticleNature structural & molecular biology2014

Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis.

Suk-Youl Park, Jung-Eun Park, Tae-Sung Kim, Ju Hee Kim, Mi-Jeong Kwak, Bonsu Ku, Lan Tian, Ravichandran N Murugan, Mija Ahn, Shinobu Komiya and 10 more

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 72 papers.

0numbers the graph read from it
0cells of the map it votes in
72citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

72 citing papers in PubMed, 113 citations in OpenAlex.

  1. Article
  2. Genetic alterations in SUPT6H are associated with neurodevelopmental disorders.Biochimica et biophysica acta. Molecular basis of disease · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. CRL4Life science alliance · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

12 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 10 institutions in 3 countries.

Suk-Youl Park1] Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2] Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Republic of Korea. [3].
Jung-Eun Park1] Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].
Tae-Sung Kim1] Laboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA. [2].
Ju Hee Kim1] Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea. [2].
Mi-Jeong Kwak1] Department of Biological Sciences, KAIST Institute for Biocentury, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea. [2].
Bonsu Ku1] Medical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea. [2].
Lan TianLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Ravichandran N MuruganDivision of Magnetic Resonance, Korea Basic Science Institute, Ochang, Republic of Korea.
Mija AhnDivision of Magnetic Resonance, Korea Basic Science Institute, Ochang, Republic of Korea.
Shinobu KomiyaDepartment of Applied Biochemistry, Tokai University, Kanagawa, Japan.
Hironobu HojoInstitute for Protein Research, Osaka University, Osaka, Japan.
Nam-Hyung KimDepartment of Animal Sciences, Chungbuk National University, Cheongju, Republic of Korea.
Bo Yeon KimChemical Biology Research Center, Korea Research Institute of Bioscience and Biotechnology, Ochang, Republic of Korea.
Jeong K BangDivision of Magnetic Resonance, Korea Basic Science Institute, Ochang, Republic of Korea.
Raymond L EriksonBiological Laboratories, Harvard University, Cambridge, Massachusetts, USA.
Ki Won Lee1] Advanced Institutes of Convergence Technology, Seoul National University, Suwon, Republic of Korea. [2] Department of Agricultural Biotechnology, Seoul National University, Seoul, Republic of Korea.
Seung Jun KimMedical Proteomics Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
Byung-Ha OhDepartment of Biological Sciences, KAIST Institute for Biocentury, Korea Advanced Institute of Science and Technology, Daejeon, Republic of Korea.
Wei YangLaboratory of Molecular Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kyung S LeeLaboratory of Metabolism, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Korea Research Institute of Bioscience and Biotechnology · KRNational Institutes of Health · USKorea Basic Science Institute · KRKorea Advanced Institute of Science and Technology · KRNational Cancer Institute · USChungbuk National University · KRHarvard University · USNational Institute of Diabetes and Digestive and Kidney Diseases · USOsaka University · JPTokai University · JP

Funding

Molecular basis of centriole duplicationZIABC011518 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LEE, KYUNG · 2013 to 2025
$11.2M
Intramural NIH HHS ZIA BC011518
6 · The paper itself

Abstract

Polo-like kinase 4 (Plk4) is a key regulator of centriole duplication, an event critical for the maintenance of genomic integrity. We show that Plk4 relocalizes from the inner Cep192 ring to the outer Cep152 ring as newly recruited Cep152 assembles around the Cep192-encircled daughter centriole. Crystal-structure analyses revealed that Cep192- and Cep152-derived peptides bind the cryptic polo box (CPB) of Plk4 in opposite orientations and in a mutually exclusive manner. The Cep152 peptide bound to the CPB markedly better than did the Cep192 peptide and effectively 'snatched' the CPB away from a preformed CPB-Cep192 peptide complex. A cancer-associated Cep152 mutation impairing the Plk4 interaction induced defects in procentriole assembly and chromosome segregation. Thus, Plk4 is intricately regulated in time and space through ordered interactions with two distinct scaffolds, Cep192 and Cep152, and a failure in this process may lead to human cancer.

Indexed as

Amino Acid SequenceCell Cycle ProteinsCentriolesChromosomal Proteins, Non-HistoneCrystallography, X-RayHEK293 CellsHeLa CellsHumansHydrogen BondingModels, MolecularMolecular Sequence DataMutation, MissenseNeoplasmsProtein BindingProtein Interaction Domains and MotifsProtein Serine-Threonine KinasesCell Cycle ProteinsCEP152 protein, humanCep192 protein, humanChromosomal Proteins, Non-HistonePLK4 protein, humanProtein Serine-Threonine Kinases

Identifiers

PMID24997597
PMCPMC4125498
OpenAlexW2028269456

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.